We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Medgenics(Regs) | LSE:MEDG | London | Ordinary Share | COM SHS USD0.0001 (REGS) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 302.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMMEDG
RNS Number : 3934B
Medgenics Inc
26 October 2009
Medgenics, Inc.
('Medgenics' or the 'Company')
26 October 2009
The Board of Medgenics announces that on 23 October 2009 Lord Leonard Steinberg
(a Director of the Company) informed the Company that on 23 October 2009 he
acquired in the market 25,000 common shares of US$ 0.0001 each ("Common Shares")
in the Company at a price of 12 pence per Common Share.
Lord Steinberg's holding of Common Shares following this purchase is 18,609,725
Common Shares representing 15.7 % of the issued share capital (excluding his
interest in warrants and convertible debentures as previously announced).
For further information, contact:
+----------------------------------------------------+---------------------------------------+
| Medgenics, Inc. | Phone: +972 4 902 8900 |
| Dr. Andrew L. Pearlman | |
| | |
+----------------------------------------------------+---------------------------------------+
| Grayling (Financial PR, UK) | Phone: +44 7900 053 536 |
| Jonathan Shillington | jonathan.shillington@uk.grayling.com |
| Alistair Scott | |
| | |
+----------------------------------------------------+---------------------------------------+
| Blomfield Corporate Finance Limited (Nominated | Phone: +44 207 444 0800 |
| Adviser) | |
| James Pinner | |
| Alan MacKenzie | |
| | |
+----------------------------------------------------+---------------------------------------+
| SVS Securities plc (Broker) | Phone: +44 207 638 5600 |
| Ian Callaway | |
| | |
+----------------------------------------------------+---------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEASEKASLNFFE
1 Year Medgenics(Regs) Chart |
1 Month Medgenics(Regs) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
